Articles related to FDA

FDA Approval of Milsaperidone Widens Door to Severe Mental Disorder Treatment

The new chemical entity is an atypical antipsychotic and the active metabolite of iloperidone (Fanapt). Its ability to cross the blood-brain barrier likely contributes to iloperidone’s clinical effects.

Psychiatry March 4th 2026

Tags: ANTIPSYCHOTICS BIPOLAR DISORDER DEVICE/DRUG APPROVALS FDA SCHIZOPHRENIA

Conexiant

FDA Approves HRT Label Changes

“We are delivering on our promise to make sure women have accurate, scientifically grounded information about the potentially life-changing benefits of HRT.” — FDA Commissioner Marty Makary, MD, MPH

Obstetrics & Gynecology February 24th 2026

Tags: CANCER RISK CARDIOVASCULAR RISK FDA HORMONE REPLACEMENT THERAPY (HRT) MENOPAUSE PRODUCT LABELING

Conexiant

FDA Expands HPV Primary Screening Options

The Aptima HPV assay uses messenger RNA detection to identify infections most likely to lead to cervical cancer.

Obstetrics & Gynecology February 11th 2026

Tags: CANCER SCREENING CERVICAL CANCER FDA HPV REGULATORY AFFAIRS WOMEN'S HEALTH

Medical Professionals Reference (MPR)

Cardamyst Nasal Spray Now Available for Self-Treatment of PSVT Episodes

64% of those who self-administered Cardamyst converted to sinus rhythm within 30 minutes compared with 31% who received placebo.

Cardiology February 10th 2026

Tags: CARDIAC ARRHYTHMIA DEVICE/DRUG APPROVALS FDA HOME HEALTHCARE

Parkinson’s News Today

FDA Grants Advanced Therapy Status to Parkinson’s Cell Treatment

Twelve months after transplantation with the lower dose, mean scores decreased by 30.6 points during off time (a 52.82% improvement from baseline) and by 12.9 points during on time (a 54.67% improvement).

Geriatrics February 5th 2026

Tags: FDA MOVEMENT DISORDERS NEUROSURGERY PARKINSON'S DISEASE (PD) REGULATORY AFFAIRS

Healthline

FDA Approves Wegovy Weight Loss Pill: How It Compares to Injectables

“People are more used to taking pills than they are taking injections” but “90% of a person’s weight is the result of what they eat. There are no magic solutions.”

Ambulatory Care Nursing January 29th 2026

Tags: DEVICE/DRUG APPROVALS DIABETES EDUCATION FDA GLP-1s OBESITY/WEIGHT MANAGEMENT

1 2 … 38 39 >>

Trending Topics:

Articles related to FDA

FDA Approval of Milsaperidone Widens Door to Severe Mental Disorder Treatment

FDA Approves HRT Label Changes

FDA Expands HPV Primary Screening Options

Cardamyst Nasal Spray Now Available for Self-Treatment of PSVT Episodes

FDA Grants Advanced Therapy Status to Parkinson’s Cell Treatment

FDA Approves Wegovy Weight Loss Pill: How It Compares to Injectables

Topics

Sources

The Healthcare Communications Network is owned and operated by IQVIA Inc. Click below to leave this site and continue to IQVIA’s Privacy Choices form

The Healthcare Communications Network is owned and operated by IQVIA Inc.

Click below to leave this site and continue to IQVIA’s Privacy Choices form